These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 546376)

  • 21. [Resistance to Ehrlich's ascites carcinoma in mice immunized with killed tumor cells].
    D'Alessandro G; Giammanco G; Barncato P
    Riv Ist Sieroter Ital; 1967; 42(6):332-49. PubMed ID: 5601777
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapeutic effect of a polyantigenic vaccine in animal tumor models.
    Colón JI; Marchand AM; Román Franco AA; Santiago Delpín EA
    Bol Asoc Med P R; 1981 Apr; 73(4):162-7. PubMed ID: 6946783
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunostimulating effect of Listeria monocytogenes, BCG and their biologically active extracts on the model of mouse ascites tumors.
    Mára M; Nedvĕdová V; Miková Z; Hyncica V
    Neoplasma; 1979; 26(6):703-10. PubMed ID: 120515
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytotoxic effects of a nitrofuran derivative on an ascites carcinoma cells.
    Ichihashi H; Muragishi H; Kanemitsu T; Kondo T
    Nagoya J Med Sci; 1969 Jul; 32(1):103-12. PubMed ID: 5347819
    [No Abstract]   [Full Text] [Related]  

  • 25. Antitumor effects of interferon preparations in mice.
    Gresser I; Bourali C
    J Natl Cancer Inst; 1970 Aug; 45(2):365-76. PubMed ID: 5514991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunotherapy of Ehrlich ascites tumor in mice].
    Jakóbisiak M
    Pol Arch Med Wewn; 1980 May; 63(5):503-9. PubMed ID: 7413475
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunity against the Ehrlich ascites carcinoma produced by bacterial endotoxins.
    Hager EB; Bailey GL; Hampers CL; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):124-5. PubMed ID: 4944208
    [No Abstract]   [Full Text] [Related]  

  • 28. Antitumor factor of regional lymph node cells in the transplantation of Ehrlich tumor cells. 3. Passive transfer of the antitumor factor.
    Nakashima Y
    Acta Med Okayama (1952); 1969 Aug; 23(4):283-90. PubMed ID: 4243561
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blastolysin, an agent potentiating the antitumor action of ionizing radiation].
    Iarmonenko SP; Syrkin AB; Treshchalin ID
    Dokl Akad Nauk SSSR; 1980; 253(6):1495-9. PubMed ID: 7428605
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the effect of the tissue substance "cornin" on transplantable malignant tumors in mice.
    Ohya T
    Acta Med Okayama (1952); 1967 Oct; 21(5):227-50. PubMed ID: 4232096
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor immunity after viral oncolysis.
    Cassel WA; Garrett RE
    J Bacteriol; 1966 Sep; 92(3):792. PubMed ID: 4288498
    [No Abstract]   [Full Text] [Related]  

  • 33. Antitumor activity of julimycin B-II.
    Matsuura S; Shiratori O; Harada Y; Katagiri K
    J Antibiot (Tokyo); 1967 Sep; 20(5):282-6. PubMed ID: 5630771
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of indirect active immunotherapy of Ehrlich carcinoma].
    De Santana CF; Da Silva IN
    Rev Inst Antibiot (Recife); 1974 Dec; 14(1-2):3-8. PubMed ID: 4471334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ascitic tumor produced by BHK-21 cells (clone 13) in hamsters exposed to whole body roentgen irradiation].
    Mayo J; Moreira JL; Lombardo JH; Conti CJ; Rivenson S
    Arch Exp Veterinarmed; 1971; 25(5):853-62. PubMed ID: 4335401
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidermal growth factor inhibits thymidine incorporation in Ehrlich ascites tumor cells in vivo.
    Lombardero J; Pérez R; Lage A
    Neoplasma; 1986; 33(4):423-9. PubMed ID: 3489898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection of lethal tumors after subcutaneous inoculation: a phenomenon of antigenic expression?
    Apffel CA; Peters JH
    J Natl Cancer Inst; 1967 Dec; 39(6):1129-39. PubMed ID: 4170428
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematogenous dissemination of tumour cells and metastases formation in Ehrlich ascites tumour.
    Kiseleva NS; Magamadov YC
    Neoplasma; 1972; 19(4):257-75. PubMed ID: 5054530
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytologic changes in Erlich ascites tumor treated with antiblastic drugs and hyperbaric oxygen.
    Ghinelli C; Pons ML; Terzano G
    Acta Cytol; 1975; 19(1):43-4. PubMed ID: 1054529
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice.
    Chedid L; Lamensans A; Parant F; Parant M; Adam A; Petit JF; Lederer E
    Cancer Res; 1973 Sep; 33(9):2187-95. PubMed ID: 4725375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.